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Summary
User surveys in telemedicine networks confirm that follow up data are essential, both for the 
specialists who provide advice and for those running the system.  We have examined the 
feasibility of a method for obtaining follow-up data automatically in a store-and-forward 
network.  We distinguish between follow-up, which is information about the progress of a 
patient and is based on outcomes, and user feedback, which is more general information about
the telemedicine system itself, including user satisfaction and the benefits resulting from the 
use of telemedicine.  In the present study, we were able to obtain both kinds of information 
using a single questionnaire.  During a 9-month pilot trial in the MSF telemedicine network, 
an email request for information was sent automatically by the telemedicine system to each 
referrer exactly 21 days after the initial submission of the case.  A total of 201 requests for 
information were issued by the system and these elicited 41 responses from referrers (a 
response rate of 20%).  The responses were largely positive.  For example, 95% of referrers 
found the advice helpful, 90% said that it clarified their diagnosis, 94% said that it assisted 
with management of the patient and 95% said that the telemedicine response was of 
educational benefit to them.  Analysis of the characteristics of the referrers who did not 
respond, and their cases, did not suggest anything different about them in comparison with 
referrers who did respond.  We were not able to identify obvious factors associated with a 
failure to respond.  Obtaining data by automatic request is feasible.  It provides useful 
information for specialists and for those running the network.  Since obtaining follow-up data 
is essential to best practice, one proposal to improve the response rate is to simplify the 
automatic requests so that only patient follow-up information is asked for, and to restrict user 
feedback requests to the cases being assessed each month by the quality assurance (QA) 
panel.
Introduction
Follow up is an integral part of consultation in medical practice.  No doctor would give advice
about a patient without attempting to follow the patient's subsequent progress and/or trying to 
obtain some feedback.  This basic principle is not altered when the consultation takes place at 
a distance (teleconsultation).  Follow-up is part of routine clinical care, conducted in order to 
confirm that the situation is evolving as expected, and to allow the diagnosis, prognosis and 
treatment to be adjusted as appropriate.  It is also important for doctors to learn from their 
successes and mistakes, as part of a reflective practice.[1]
Thus it is not surprising that surveys in telemedicine networks show that the specialists who 
provide advice wish to receive follow-up data about the cases they have worked on.  In a 
survey of telemedicine users in Médecins Sans Frontières (MSF), almost all specialists 
wanted follow-up information (52% considered follow up desirable and 47% considered it 
necessary or mandatory).[2]  In a survey of specialists in the Swinfen telemedicine network, 
83% stated that they would like to receive follow-up information about the patient.[3]  We 
assume that provision of follow-up data is useful in keeping the specialists motivated, i.e. to 
ensure their continued participation in the telemedicine network and their availability to 
provide advice.  It is also probably the only way that specialists can improve their service, 
since many of them will be based in high-income countries and without feedback it is 
impossible for them to know if their answers are useful;  prompt feedback from the referrer 
may be perceived as a mark of gratitude for the service provided, which is important since 
many specialists volunteer their time and expertise for free.  While it can reasonably be 
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assumed that the provision of follow-up data is useful for many reasons, there is no literature 
about this (an experiment to test the assumption would be difficult, although not impossible).
Follow-up is also useful for those running the network, especially if a research study is to be 
conducted.  Follow-up provides information about the value of the telemedicine consultations,
and about the performance of individual specialists.  Information about the latter is very 
valuable for the case coordinator in the allocation process, since experience shows that some 
specialists answer more quickly and comprehensively than others.  Finally, providing follow-
up data is probably good discipline for the referrers, as it makes them think about the progress
of their patients and about the value of the telemedicine advice they have received.
In the present paper we distinguish between patient follow-up, which is information about the 
progress of a patient and is based on outcomes, and user feedback, which is more general 
information about the telemedicine system itself, including user satisfaction and the benefits 
resulting from the use of telemedicine.
Objectives
The primary Research Question was whether a method could be developed for obtaining 
follow-up data automatically in a general teleconsulting network which was providing a 
service in low resource settings.  The secondary Research Question was whether it was 
feasible to obtain both follow-up data and user feedback simultaneously.
Methods
The present study required the development of a method to obtain data from the referrers and 
then a demonstration of its feasibility in practice.  We combined the collection of both kinds 
of information into a single questionnaire, i.e. it represented a progress report.
The work was performed in two stages:
(1) development of an information-collection tool
(2) demonstration of its feasibility in the MSF telemedicine network.  Details of the 
network have been published elsewhere.[2,4]
Ethics permission was not required, because patient consent to access the data had been 
obtained and the work was a retrospective chart review conducted by the organisation's staff 
in accordance with its research policies.
Development of the questionnaire
A questionnaire was developed by a consensus between three experienced telemedicine 
practitioners (two were medical specialists with field experience).  It was based on accepted 
tools used in previous studies.[3,5]  The final questionnaire was evaluated and approved by an
independent evaluator.
The final questionnaire consisted of 12 questions, which concerned both patient follow-up and
user feedback, Table 1.  The questions about follow-up concerned the referrer's opinion about 
whether the eventual outcome would be beneficial for the patient.  The questions about 
feedback concerned the referrer's opinion about whether the process was satisfactory (e.g. the 
way that the referral had been handled in the telemedicine network) and what the benefits 
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were, for the patient and doctor.
Automatic request for information
Modifications were made to the telemedicine system so that automatic requests for progress 
reports were sent to every referrer at a pre-determined interval after a new case had been 
submitted.  The request allowed the referrer to log in to the server and then provided a link for
the referrer to respond to the questionnaire.
Demonstration of feasibility
To demonstrate the feasibility of the proposed approach, automatic requests for progress 
reports were issued in respect of cases submitted in the MSF telemedicine network for a 9-
month period starting in October 2013.  An email request was sent automatically by the 
telemedicine system to each referrer exactly 21 days after the initial submission of the case.  
When the referrer completed the progress report, an email notification was sent 
simultaneously to the expert(s) involved in the case and to the case-coordinators.
Analysis of responses
Responses to the requests were analysed approximately four weeks after the final request had 
been sent.  The free-text comments were examined and, based on a content analysis, the main 
themes were extracted.
Results
Analysis of responses
During the pilot trial, 201 requests for progress reports were issued by the system and these 
elicited 41 responses from referrers (a response rate of 20%).  The responses were largely 
positive.  For example, excluding the Don't-know and Missing responses, 95% of referrers 
stated that they found the advice helpful, 90% said that it clarified their diagnosis and 94% 
said that it assisted with management of the patient.  In addition, 95% said that the 
telemedicine response was of educational benefit to them.  The responses are summarised in 
Table 2a.
The qualitative analysis of the free comments confirmed this positive feedback from the 
responders, see Table 2b.  The expert advice was considered by the referrer as “clear, 
comprehensive and useful”, helping both in the clinical management (diagnosis and 
management) and the information delivered to the patient and relatives.  Referrers considered 
that the non-availability of an investigation or treatment that had been suggested was the main
limitation in following the advice received.  For this reason, some referrers emphasised the 
importance of making the expert aware of the constraints of the referral setting and the limited
resources available.
Satisfaction with the system was also very high and the words used by responders emphasised
the efficiency of the system ("excellent, very good quality, quick, practical …").  In terms of 
benefit, avoiding unnecessary referral to a higher level of health care or avoiding further 
specialised consultation were mentioned as the main reasons for cost savings.
Analysis of non-responses
During the pilot trial, questionnaires were completed for 41 cases.  That is, no questionnaire 
was completed for the other 160 cases.  These two groups of cases might have differed in 
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some way, and any difference might be a reason why the referrers decided to respond or not to
respond.  Various characteristics of the two groups were therefore compared.  The median age
of the patients in Group 1 (those with responses) was 27.5 years, and the median age of the 
patients in Group 2 (those without responses) was 22.0 years.  However, the difference was 
not significant (P=0.13).  There were no significant differences in the gender of the patients in
the two groups, nor the type of queries required to answer them, nor the number of queries for
each case, see Table 3.
Responders and non-responders
Six referrers provided progress reports for every request they received, see Table 4a.  
However, the majority provided either some reports, or none, see Table 4b.  There were no 
obvious differences between the three groups (responders to all, some or none of the requests)
in the characteristics available for comparison, see Table 6.
Discussion
The present work shows that both patient follow-up data and user feedback information can 
be obtained in a telemedicine network, via an automatic questionnaire.  In a 9-month pilot 
trial, there was a response rate of 20%.  How can we interpret this response rate?  In physician
surveys conducted in industrialised countries, a response rate of say 50-60% would be 
considered normal.[6,7]  However, there is little published data about the response rate in 
online surveys of doctors in developing countries, and even less about  the response rate in 
online surveys of doctors concerning the use of telemedicine in developing countries.  A 
reasonable comparator is the study by Zolfo et al., of health-care workers using store-and-
forward telemedicine in the management of difficult HIV/AIDS cases, which had a response 
rate of 19%.[8]
The dangers of a low response rate are non-response bias (if the answers provided by 
respondents differ from the potential answers of those who do not answer), and response bias 
(if respondents tend to give answers that they believe that the questioner wants).  Analysis of 
the characteristics of the referrers who did not respond, and the cases, did not suggest 
anything different about them in comparison with referrers who did respond.  The comparison
of referrers was however limited by the restricted information available about them.  For 
reasons of information security, the telemedicine system stores little personal information 
about the users, and the accounts tend to be used by more than one person as staff are rotated 
through the field.
We were not able to identify obvious factors associated with a failure to respond.  The 
response rate may therefore simply reflect the pressures of working in low resource settings, 
and especially, the high turnover of field staff, which acts against the treating doctor being in 
post when a request for follow-up data is made some weeks later.
Measures to increase survey response rates are reasonably well understood, and include 
offering financial incentives, and following up online requests with copies of the survey sent 
out on paper.  These are probably not appropriate in the present context.  Nonetheless, it 
would seem prudent if this technique is to be adopted into routine service to try and increase 
the response rate.  This raises a number of questions for future research:
1. when should follow-up data be requested? i.e. is 21 days the right time?  Other 
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work[2] suggests that a shorter interval, such as one week, would be appropriate, see 
Table 5a
2. is there an optimum time interval for all patients, or does the optimum time vary, 
depending on the speciality being consulted?
3. what is the right number of questions? i.e. is 12 questions too many?  Reducing the 
survey to 2-3 questions might make a response more likely
4. is it appropriate to ask for user feedback each time that a follow up report is 
requested?  Should requests for user feedback be made separately from requests for 
follow-up data (and less frequently)?
5. is a single follow-up report sufficient, or should there be say a short-term and a longer-
term report?
As mentioned in the Introduction, it is highly desirable to obtain follow up data for each case. 
Even though there are other ways to obtain follow up information, e.g. from the regular 
dialogue between expert and referrer, the benefit of using an automatic request is that a 
standardized report is obtained for each case.  Thus the main problem in practice is the low 
response rate, and how best to encourage the referrer to complete the questionnaire.  One 
potential way to increase the response rate would be to reduce the number of questions, in 
order to allow the referrer to answer within 1-2 minutes.  As shown in a previous survey,[2] 
the main reasons given for not answering were a lack of time > forgotten to update > patient 
lost to follow up > difficulties with Internet access (Table 5a, 5b).  This is why we propose to 
separate the reporting of follow up data from obtaining user feedback.
If user feedback is solicited separately from the follow-up data, then a natural time to request 
it would be when the monthly quality assurance (QA) review is conducted.[9]  This activity 
involves an expert panel making an assessment of a recent case that has been selected at 
random.  If user feedback is requested from the referrer for the same case, then both the 
panel's and the referrer's views on the quality of the teleconsultation can be compared.
Finally, it is worth noting that specialists tend to underestimate the value of their responses.  
In a recent survey,[3] Patterson examined the perceived value of telemedicine advice.  There 
were 62 cases where it was possible to match up the opinions of the referrer and the 
consultants about the value of a specific teleconsultation.  In 34 cases (55%) the referrers and 
specialists agreed about the value.  However, in 28 cases (45%) they did not: specialists 
markedly underestimated the value of a consultation compared to referrers.  A survey of MSF 
telemedicine users found a similar phenomenon.[2]  This reinforces the importance of 
obtaining user feedback from the referrers, who are best placed to evaluate the benefits to the 
patient.
Conclusion
Obtaining data from referrers by automatic request is feasible.  The technique provides useful 
information for specialists and for those running the network.  The modest response rate could
be improved.  Since obtaining follow-up information on each case is essential to best practice,
a proposal to improve the response rate is to re-design the follow up questionnaire to be as 
simple as possible, and to obtain user feedback separately, by sending a more detailed 
questionnaire in parallel with the randomly selected cases reviewed each month by the QA 
expert panel.
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Table 1.  Progress report questions.  The questions concern follow-up (patient outcomes) or 
user feedback.  User feedback encompasses satisfaction with the service (S) and benefit to the
patient (Bp), the doctor (Bd) and the organisation (Bo).
Question Question type
(1) Was the case sent to an appropriate expert? Feedback (S)
(2) Was the answer provided sufficiently quickly? Feedback (S)
(3) Was the answer well-adapted for your local environment? Feedback (S)
(4) Were you able to follow the advice given? Feedback (Bd, Bp)
(5) If NO, could you explain briefly why not Feedback (Bd, Bp)
(6) Did you find the advice helpful? Feedback (Bd, Bp)
(7) If YES, did it- (tick any that apply) -
- Clarify your diagnosis? Feedback (Bd, Bp)
- Assist with your management of the patient? Feedback (Bd, Bp)
- Improve the patient's symptoms? Follow-up
- Improve function? Follow-up
- Any other reason? Please specify Follow up / Feedback
(8) Do you think the eventual outcome for the patient will be beneficial for the patient? Follow-up
(9) Was there any educational benefit to you in the reply? Feedback (Bd)
(10) Was there any cost-saving as a result of this consultation? (tick any that apply) Feedback (B)
- saving for the patient/family? Feedback (Bp)
If YES, please explain briefly Feedback (Bp)
- saving for the hospital/clinic? Feedback (Bo)
If YES, please explain briefly Feedback (Bo)
(11) Please add any other comments about this case specifically Follow up / Feedback
(12) Please add any other comments about the service generally Feedback (S)
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Table 2a.  Summary of 41 responses
Missing Don't
know
No Perhaps Yes Yes (% of
definite
responses
)
(1) Was the case sent to an appropriate expert? 4 37 100
(2) Was the answer provided sufficiently quickly? 6 35 100
(3) Was the answer well-adapted for your local environment? 1 8 32 80
(4) Were you able to follow the advice given? 15 26 63
(5) If NO, could you explain briefly why not 16 comments
(6) Did you find the advice helpful? 2 2 37 95
(7) If YES, did it- (tick any that apply)
- Clarify your diagnosis? 12 3 26 90
- Assist with your management of the patient? 9 2 30 94
- Improve the patient's symptoms? 15 16 10 38
- Improve function? 15 16 10 38
- Any other reason? Please specify 16 comments
(8) Do you think the eventual outcome for the patient will be beneficial for the 
patient?
8 3 14 16 48
(9) Was there any educational benefit to you in the reply? 1 2 38 95
(10) Was there any cost-saving as a result of this consultation? (tick any that apply)
- saving for the patient/family? 2 5 22 12 35
If YES, please explain briefly 11 comments
- saving for the hospital/clinic? 10 4 14 13 48
If YES, please explain briefly 12 comments
(11) Please add any other comments about this case specifically 18 comments
(12) Please add any other comments about the service generally 17 comments
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Table 2b.  Main themes in the free-text responses.  Note that one answer may include more than one theme
Question No of 
answers
Type of 
comments
Main themes, with the number of recurrences in parentheses
Q5. If you could not follow the advice given, could
you explain briefly why not
16 Main points Investigation not available (5)
Treatment unavailable (3)
Inability to perform investigation (2)
Disagreement on expert diagnosis (2)
Discharged against medical advice (2)
Cost not affordable by patient 
Patient lost to follow up 
Advice not appropriate
Not applicable 
Q7e. Any other reason that you found the advice 
helpful
16 Main points Diagnosis clarified or confirmed (2)
Differential diagnosis discussed (2)
Helpful discussion about diagnosis and management (2)
Triggered decision to transfer patient to specialist (2)
Confidence in experienced specialist
Advice “clear, comprehensive” 
Useful information about disease (nature, management, complication signs) for patient and relatives
Technical advice about how to take an X-ray
Support in CT scan interpretation 
Other 
comments
Patient left against medical advice
Difficulties in implementing treatment advised (e.g. chronic disease)
Treatment still in progress: too early to assess
Not applicable
Q10b. If there was a saving for the patient/family, 
please explain briefly
11 Main points Avoid unnecessary referral to capital (4) because diagnosis given or chronicity of disease confirmed
No further need for the patient to consult local specialists, saving both money and time (3)
“Best diagnosis” obtained
Clear information given to family and patient
Avoid unnecessary harmful treatment or costly hospitalisation
Early referral suggested for congenital cardiac disease (presenting from further complications)
Specialised consultation not affordable by patient
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Q10d. If there was a saving for the hospital/clinic, 
please explain briefly
12 Main points Avoid unnecessary referral to specialist (3)
No need to send investigation for interpretation (3)
Avoid unnecessary and costly investigation
Ambulatory management avoiding costly hospitalisation
Strengthened local staff decision to avoid costly referral
Clear information helped management
Not applicable (2)
Q11. Please add any other comments about this 
case specifically
18 About patient 
outcome
About advice
About case
To be 
improved
Patient lost to follow up (making evaluation difficult), patient left, patient died 
“Very helpful” both for diagnosis and patient information, “excellent”, “very practical and realistic 
advice with our set up”
Helpful for X ray interpretation 
Useful guidance for specialised treatment
Critical cases with ICU transfer (2)
Difficult case, but a feeling to have “offered everything we can”
Difficult case, but afeeling that “comments improved both patient management and staff knowledge”
Specialised surgical treatment performed 
Problem of implementing expert advice in limited resource-settings
More detailed X-ray interpretation for educational purposes
X-ray interpretation not appropriate 
Difficult to upload a large file to the server
Expert to be better informed about limited resource settings to adapt better their advice
Appropriateness and usefulness of expert advice improved after several emails (from “Eurocentric -- 
further investigations and management recommended -- to field centred)
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Q12. Please add any other comments about the 
service generally
17 Service
Other 
comments
“Excellent” (3)
“Very rapid and extremely useful to the field and consequently the patients”
“Very useful- practical and informative”
“Appreciated a lot” (2), “appreciated really”
 “Important with benefit for both client and medical personnel”
“Effective” because quick answer
“Very good quality and helpful”
“Is the best.”
“Really quick with the best of idea.”
“Good quality and very quick.”
“Advice adapted to MSF environment.”
“Good way of communication.”
Using email instead of the telemedicine system has delayed the expert advice
A delay in getting the answer reduces the benefit of expert advice
Headquarter's support is appreciated
“Helpful to have opinions from different specialists on submission of one case”
“It is great to be able to have expert advice in a very short time. It helps a lot to evaluate better and to
make the right decisions for unknown diseases/ symptoms. Great, great thanks”
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Table 3.  Characteristics of the cases 
With reports
(n=41)
Without reports
(n=160)
P-value
Median age, years (IQR) 28 (9-37) 22 (4-35) Z=-1.5, P=0.13
Number of patients
Young* 14 (35%) 70 (45%)
chi2=3.1, P=0.21;
P-value for trend=0.12Adult 23 (58%) 80 (52%)
Older 3 (8%) 4 (3%)
Gender 22 M, 19 F 77 M, 77 F chi2=0.2, P=0.68
Type of queries
chi2=4.5, P=0.34
Internal medicine 27 (34%) 89 (28%)
Paediatrics 15 (18%) 96 (30%)
Radiology 20 (25%) 71 (22%)
Surgery 14 (18%) 45 (14%)
Other 4 (5%) 19 (6%)
No of queries per case
1 20 (49%) 59 (37%)
chi2=7.1, P=0.13;
P-value for trend=0.82
2 10 (24%) 64 (40%)
3 5 (12%) 23 (14%)
4 5 (12%) 7 (4%)
>5 1 (2%) 7 (4%)
*age groups defined as: young 0-17y; adult >17-60y; older >60y
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Table 4a.  Referrers who provided progress reports for all requests.  Note that some cases 
were submitted from headquarters staff on behalf of field doctors in low-income countries.
Referrer ID
no Country
No of progress reports
provided % answered
1275 Chad 4 100
2444 Uganda 1 100
2491 Australia 1 100
2323 Germany 1 100
2475 Switzerland 1 100
368 Yemen 1 100
Total 9
14
Table 4b.  Referrers who provided some or no progress reports.  Note that some cases were 
submitted from headquarters staff on behalf of field doctors in low-income countries.
UNANSWERED
REQUESTS
ANSWERED
REQUESTS
Refer
rer ID
no Country
No of
requests % answered
No of
progress
reports
provided
%
answered
351 Cambodia 17 0 5 23
354 Kenya 16 0 3 16
180 South Sudan 12 0
276 Tajikistan 8 0 2 20
356 Sudan 8 0
254 South Sudan 8 0 1 11
211
Democratic Republic of the 
Congo (Kinshasa) 8 0 1 11
112 Uganda 7 0 1 13
298 France 6 0 1 14
1354 Myanmar, Burma 6 0
2161 Central African Republic 5 0
163 Ethiopia 5 0
310
Democratic Republic of the 
Congo (Kinshasa) 5 0 4 44
2170
Democratic Republic of the 
Congo (Kinshasa) 5 0 1 17
1263 South Africa 4 0 1 20
1274 Chad 3 0 1 25
345 South Sudan 3 0
2459
Democratic Republic of the 
Congo (Kinshasa) 3 0 1 25
315 Malawi 2 0 2 50
2478 Jordan 2 0
75 Pakistan 2 0
1279 Guinea 2 0 4 67
193 Papua New Guinea 2 0 1 33
2019 Syria, Syrian Arab Republic 2 0
2480 South Sudan 2 0
335 Sierra Leone 2 0 1 33
1356 Syria, Syrian Arab Republic 1 0
2167
Democratic Republic of the 
Congo (Kinshasa) 1 0
2163 Central African Republic 1 0
15
1352 Swaziland 1 0
2428 Spain 1 0
2445 Afghanistan 1 0
2476 Mozambique 1 0
1222 Yemen 1 0
2423 Central African Republic 1 0
1258 Kyrgyzstan 1 0
2455 Myanmar, Burma 1 0
2301 France 1 0
2468
Democratic Republic of the 
Congo (Kinshasa) 1 0 2 67
2498 Uzbekistan 1 0
129 Bangladesh 1 0
2442 Canada 1 0
Total 161 32
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Table 5a.  Data from a previous survey*.  Responses from referrers
Question to referrer 
Yes / 
multiple 
choice
No Unknown Total answered Skipped
Majority 
response
Q37: Did you give the specialist any feedback about the patient? 41% 59% - 34 31 No 59% 
Q38: If no, was it because …
-patient lost to follow up
-lack of time
-forgotten to update
-feeling it was not necessary
-worse outcome or patient died
-difficulties with Internet access
14
30
24
16
3
14
NA NA 37 43 Lack of time30%
Q39: Do you think that feedback about the patient is ...
-optional
-desirable
-necessary
-mandatory
14
43
30
14
NA NA  27 Desirable43%
Q40: in your opinion, is the patient likely to be available for follow-up in 2-4 
months? 22% 46% 32% 37 27 No 46%
Q41: in your opinion, when would it be relevant to give follow-up information?
(i.e. completing a progress report)
-after 1 week
-after 2 weeks
-after 1 month
-after 3 months
-after 6 months
53
24
18
5
0
NA NA 38 28 After 1 week53%
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Table 5b.  Data from a previous survey*.  Responses from specialists
Question to specialist
Yes / 
multiple 
choice
No Unknown Total answered Skipped
Majority 
response
Q37: Did you receive any follow-up information about this patient? 8% 92% - 63 36 No 92% 
Q38: Do you think that feedback about the patient is ...
-optional
-desirable
-necessary
-mandatory
1
52
29
18
NA NA 67 32 Desirable52%
*Data from the MSF survey (50 questions) sent to 294 referrers and 254 specialists (in French and English) in December 2013.[2]
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Table 6.  Characteristics of those responding to all, some or none of the requests
All Some None P-value
No of referrers 6 17 25
No of referrals 15 388 415 One-way ANOVA F=0.77,
P=0.47
Mean referrals per doctor 2.5 22.8 16.6
Sex
Male 2 2 3 Males vs Females:
chi2=0.5, P=0.77
P-value for trend=0.73
Female 1 3 3
Unknown 3 12 19 M/F vs Unknown:
chi2=1.6, P=0.45
P-value for trend=0.25
Country of referrers
Low-income countries 3 12 16 chi2=5.1, P=0.08
P-value for trend=0.17Proxy countries 3 1 3
MSF regions
OCA 2 7 9 chi2=7.5, P=0.48
OCB 0 3 2
OCBA 0 2 7
OCG 1 1 3
OCP 3 4 4
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